Item 5. Market for Registrant’s Common Equity
Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
On August 31, 2021, the Company commenced the
trading of its common stock on the Nasdaq Capital Market under the symbol “FCUV.” From
January 28, 2022, to September 22, 2024, the Company’s shares traded on the Nasdaq Global Market. Starting on September 23, 2024,
our securities were transferred for trading in the Nasdaq Capital Market. On February 3, 2025, the last reported sale price
of our common stock as reported on the Nasdaq Capital Market was $6.09 per share.
On September 23, 2014, our common stock was verified
for trading on the OTCQB Market under the trading symbol “FCUV.” Prior to that time, there was no public market for our stock.
The following table sets forth for the indicated periods the high and low intra-day sales price per share for our common stock on the
Nasdaq Global Market (as applicable) for the four quarters of 2023 and 2024. As of September 23, 2024, our common stock trades upon the
Nasdaq Capital Market.
High
Low
2023: First Quarter
$
47.10
$
23.70
2023: Second Quarter
$
24.60
$
14.50
2023: Third Quarter
$
19.70
$
15.00
2023: Fourth Quarter
$
21.70
$
13.70
2024: First Quarter
$
17.90
$
3.40
2024: Second Quarter
$
4.30
$
2.30
2024: Third Quarter
$
4.70
$
1.80
2024: Fourth Quarter
$
4.90
$
2.10
Holders.
As of December 31, 2024, there were 355 record
holders of 7,153,647 shares of the Company’s common stock. The number of record holders was determined from the records of our transfer
agent and does not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers,
and registered clearing agencies. The transfer agent of our common stock is VStock Transfer, LLC.
Dividends.
The Company has not paid any cash dividends to
date and does not anticipate or contemplate paying dividends in the foreseeable future. It is the present intention of management to utilize
all available funds for the development of the Company’s business. However, we cannot provide any assurance that we will or will
not declare or pay cash dividends on our common stock. Any future determination to declare cash dividends will be made at the discretion
of our Board of Directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements,
general business conditions and other factors that our Board of Directors may deem relevant.
36
Securities Authorized for Issuance Under Equity Compensation Plans
On December 15, 2018, our Board of Directors presented
the 2018 Equity Incentive Plan to the shareholders. On December 17, 2018, the holders of 63.051% of our issued and outstanding shares
of common stock adopted a resolution by written consent without a meeting adopting the 2018 Equity Incentive Plan. The plan reserves an
aggregate of 100,000 shares of the Company’s common stock, which provides for the payment of various forms of incentive compensation
to employees, consultants, executives, and directors of the Company. The 2018 Equity Incentive Plan provides for the grant of the following
types of stock awards: (i) incentive stock options; (ii) non-statutory stock options; (iii) stock appreciation rights; (iv) restricted
stock awards; (v) restricted stock unit awards; and (vi) other stock awards. Under the 2018 Equity Incentive Plan, a ten percent stockholder
will not be granted an incentive stock option unless the exercise price of such option is at least one hundred and ten percent of the
fair market value on the date of grant and the option is not exercisable after the expiration of five years from the grant date. The Board
of Directors determines the vesting schedule of the grants with broad discretion. On August 6, 2019, each member of the Board was granted
4,500 options to purchase shares at $38.00 per share. On December 11, 2020, each member of the Board was granted 2,250 options to purchase
shares at $20.00 per share. On December 31, 2021, each member of the Board was granted 2,250 options to purchase shares at $59.10 per
share. On December 30, 2022, each member of the Board was granted 2,250 options to purchase shares at $42.70 per share. On January 2,
2024, each member of the Board was granted 2,250 options to purchase shares at $15.00 per share.
Recent sales of unregistered securities.
None.
Issuer Purchases of Equity Securities
The following table shows the repurchases made
in 2023 and 2024.
Period
(a) Total number of shares (or units) purchased
(b) Average price paid per share (or unit)
(c) Total number of shares (or units) purchased as part of publicly announced plans or programs
( d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
April 2023
4,399
$19.92
4,399
–
May 2023
11,305
$18.71
15,704
–
June 2023
7,600
$15.99
23,304
–
November 2023
1,900
$16.35
25,204
–
December 2023
1,100
$15.72
26,304
–
October 2024
40,983
$2.58
67,287
–
November 2024
19,217
$2.59
86,504
–
December 2024
45,464
$2.74
131,968
–
Item 6. [RESERVED]
37